NCI The FY26 funding package gave NCI a raise, but the institute’s buying power is 18% less than it was two decades agoLowy: “We still have percentiles, but we’re not allowed to make awards exclusively on the basis of payline.” February 13, 2026Vol.52 No.06By Jacquelyn Cobb
NCI NCAB ad hoc group approves seven new, reissue concepts February 13, 2026Vol.52 No.06By Sara Willa Ernst
NCI Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural researchThe group replaced the NCI Board of Scientific Advisors February 06, 2026Vol.52 No.05By Claire Marie Porter
NCI In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook December 05, 2025Vol.51 No.44By Jacquelyn Cobb
NCINews Analysis Cancer centers adapt to life without site visits as NIH changes CCSG review October 31, 2025Vol.51 No.40By Paul Goldberg
NCI Anthony G. Letai to be named NCI directorThe Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say September 25, 2025Vol.51 No.35By Claire Marie Porter and Paul Goldberg
NCI NCI releases names of members of ad hoc working group—filling the void left by BSA September 19, 2025Vol.51 No.34By Sara Willa Ernst
NCI Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost September 05, 2025Vol.51 No.32By Jacquelyn Cobb
NCI NCI paylines to drop to 9th percentile amid CRs and uncertainty December 06, 2024Vol.50 No.45By Jacquelyn Cobb
